“Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, NGS, Ultrasound, Microarray, PCR), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Sex Chromosome Abnormalities), & End User - Forecast to 2027”
Non-Invasive Prenatal Testing Market states that the global non-invasive prenatal testing market will increase at a CAGR of 17.1% from 2019 to 2027 to exceed $13.6 billion by 2027.— Growing incidence of genetic disorders and advancements in genome sequencing technologies has made prenatal screening procedure imperative to provide tailored diagnosis of fetal genetic disorders. Meticulous Research® in its latest publication on
The growth in the non-invasive prenatal testing market is mainly attributed to shifting trend towards childbirth at an advanced maternal age, rising occurrences of chromosomal abnormalities, and improvements in reimbursement scenario for NIPT. In addition, rising awareness regarding non-invasive prenatal testing and untapped market potential in the emerging economies offer significant growth opportunities for the players operating in non-invasive prenatal testing market.
To provide efficient analysis, Meticulous Research® has segmented this market on the basis of Product & Solution (Consumables, Systems, Software, Service), Method (Ultrasound Screening, Cell Free DNA Screening), Application (Trisomy, Microdeletions, Sex Chromosomal Abnormalities), End-user (Diagnostic Laboratories, Hospitals, Academic & Research Institutes) and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Wherein, geographically, North America commanded the largest share of the global non-invasive prenatal testing market followed by Europe. The major share of North America is mainly attributed to the high diagnostic and treatment rate of trisomy disorders in the region and improving reimbursement scenario for NIPT services in the U.S.
In terms of product, the consumables segment accounted for the largest share of the NIPT products market in 2018. The large share of this segment is mainly attributed to the increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and improvement of approvals or licenses for assays.
In terms of method, the ultrasound screening methods commanded the largest share of the global non-invasive prenatal testing market in 2018; due to growing technological advancements like use of 3D and 4D ultrasound imaging, innovations leading to miniaturization of devices, and increasing awareness about the advantages offered by these devices.
On the basis of application, trisomy detection segment accounted for the largest share of this market in 2018 due to rising incidences of trisomies due to increasing maternal age, higher accuracy and lower cost of NIPT methods to detect trisomy as compared to other invasive methods.
On the basis of end users, diagnostic laboratories accounted for the largest share of NIPT market, in 2018; as majority of the tests are performed in third-party clinical labs. Availability of trained technicians and we-equipped infrastructure are some of the reasons for larger share of this segment in the global non-invasive prenatal testing market.
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market including Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), PerkinElmer Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Eurofins LifeCodexx (Germany), Natera, Inc. (U.S.), Igenomix S.L (Spain), F. Hoffmann-La Roche Ltd (Switzerland), and Yourgene Health plc (U.K.).
Click the link to Purchase Report NOW!! https://www.meticulousresearch.com/buy_now.php?pformat=369&vformat=1094
Market Study based on –
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.2.1. Increase in Progressive Maternal Age
4.2.2. Rise in Occurrences of Chromosomal Aneuploidies Among Foetus
4.2.3. Availability of Reimbursement Scenario for NIPT
4.2.4. Development of Advanced and New Technologies and Non-Invasive Parenteral Testing Products
4.3.1. High Cost of the Non-invasive Prenatal Screening Techniques
4.4.1. Rising Awareness Regarding NIPT
4.4.2. Untapped Emergence of New Market
4.5.1. Reliability of the Tests
5. Global NIPT Market, by Product and Solution
5.3.1. Nuchal Translucency Ultrasound Devices
5.3.2. Next-Generation Sequencing Systems
5.3.4. Polymerase Chain Reaction Instruments
6. Global NIPT Market, by Method
6.2. Ultrasound Screening
6.3. Cell-Free DNA Screening
Fill the Pre-Order Enquiry form for the report - https://www.meticulousresearch.com/enquire-before-buying/cp_id=5068
7. Global NIPT Market, by Application
7.3. Microdeletion Syndrome
7.4. Sex Chromosome Abnormalities
7.5. Other Applications
8. Global NIPT Market, by End User
8.2. Diagnostic Laboratories
8.4. Academic & Research Institutes
9. Global NIPT Market, by Geography
9.2. North America
9.5. Latin America
9.6. Middle East & Africa
10. Competitive Landscape
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis, By Company (2018)
11. Company Profiles
11.1. Illumina, Inc.
11.1.1. Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. Strategic Developments
11.2. Thermo Fisher Scientific Inc.
11.2.1. Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.3. PerkinElmer, Inc.
11.3.1. Business Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. Strategic Developments
11.4. Agilent Technologies, Inc.
11.4.1. Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.5. Beijing Genomics Institute
11.5.1. Business Overview
11.5.2. Product Portfolio
11.5.3. Strategic Developments
11.6. Eurofins LifeCodexx AG
11.6.1. Business Overview
11.6.2. Financial Overview
11.6.3. Product Portfolio
11.6.4. Strategic Developments
11.7. NATERA, INC.
11.7.1. Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.7.4. Strategic Developments
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. Laboratory Corporation of America Holdings
11.9.1. Business Overview
11.9.2. Financial Overview
11.9.3. Product Portfolio
11.9.4. Strategic Developments
11.10. F. Hoffman-La Roche Ltd.
11.10.1. Business Overview
11.10.2. Financial Overview
11.10.3. Product Portfolio
11.10.4. Strategic Developments
11.11. Yourgene Health
11.11.1. Business Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments
11.12. GE Healthcare
11.12.1. Business Overview
11.12.2. Financial Overview
11.12.3. Product Portfolio
11.12.4. Strategic Developments
12.2. Available Customization
👉 ……..Continue to read detail research on NIPT market then Download Sample Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=5068https://www.meticulousresearch.com/download-sample-report/cp_id=5068
🔹More Trending Reports by Meticulous Market Research:
Digital Diabetes Market by Product (SMBG, CGM, Smart Insulin Pump, Smart Insulin Pens, Software, Apps), End User (Home Care, Hospitals and Clinics), and Geography–Global Forecast to 2025 @ https://www.meticulousresearch.com/product/digital-diabetes-market-4946/
Next Generation Sequencing Services Market by Service Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing), Technology (Sequencing by Synthesis, Nanopore, SMRT), Application (Clinical Diagnosis, Biomarker Discovery), and End User – Global Forecast to 2025 @ https://www.meticulousresearch.com/product/next-generation-sequencing-ngs-services-market-5041/
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Pune, India
Phone: +91 744-7780008
Release ID: 88942667